| Industry Range | | Price / Earnings | N/A | |
| Book Value | 0.00 | |
| Earnings Per Share | -$0.02 | |
| Price To Sales Ratio | 32.09 | |
| Price To Book Ratio | 17.65 | |
| Price To Tangible Book Ratio | 17.69 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 32.9M | |
| Float (MRQ) | 63.13% | |
| Shares Outstanding (MRQ) | 162.6M | |
| Short Interest as a % of Float (MRQ) | N/A | |
| Shares Held By Institutions (MRQ) | N/A | |
| Industry Range | | Sales | $247.6K | |
| Gross Margin | 23.88% | |
| Net Profit Margin | -1,024.56% | |
| EBIT Margin | -819.83% | |
| EBITDA Margin | -817.98% | |
| Operating Margins | -819.83% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 0.64 | |
| Quick Ratio (MRQ) | 0.51 | |
| Total Debt/Equity Ratio (MRQ) | 74.77 | |
| Debt/Common Equity Ratio (MRQ) | 74.77 | |
| Industry Range | | Return on Equity | -1,439.07% | |
| Return on Assets | -212.34% | |
| Asset Turnover | 0.21 | |
| Receivables Turnover | 2.14 | |
| Inventory Turnover | 0.89 | |
| Industry Range | | EPS Growth Annual | -77.55% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | N/A | |
| Current Payout Ratio | N/A | |
*TAUG does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.87%